The multimodal MOAs (surface lockdown of HER2 to inactive clusters and internalization, followed by degradation) abrogated proliferative signaling, led to profound apoptosis in HER2-dependent cancer cells and finally induced pronounced tumor regression in the N-87 in vivo model. Here, ERBB2 is linked to cancer.